Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
Gary Anandasangaree’s Vic Toews Moment Shows the Government Has Lost Its Way on Lawful Access 
Government Moves to Shut Down Lawful Access Hearing In Order To Fast Track Passing the Bill This Week 
Canada’s Digital Super-Regulator: Bill C-36 Pushes Out the Privacy Commissioner and Hands Private Sector Privacy to an Overloaded Commission 
The Commission: How Bill C-34 Creates an Internet Super-Regulator That Will Touch the Lives of Millions of Canadians 
The Law Bytes Podcast, Episode 272: Build Canada’s Lucy Hargreaves on Canada’s AI Strategy and the Need to Shift From Being Users to Builders
